Discovery of Novel Small Molecule CB2 Agonist for the Treatment of Glioblastoma Tumors
Marianna Király, Derick K. Okwan-Duodu, Albert J. Wong, Joseph F. Foss, Thomas J. Giordano
This paper demonstrates that the CB2 agonist NTRX-07 significantly extends GBM mouse survival without prior radiotherapy or TMZ, and is safe in preclinical models.
bioRxiv · Dec 16, 2023 · PreprintNeuroscience